Randomized, double-blind, multicenter trial on treatment of frequency, urgency and incontinence related to detrusor hyperactivity: oxybutynin versus propantheline versus placebo.

[1]  J. Gajewski,et al.  Oxybutynin versus propantheline in patients with multiple sclerosis and detrusor hyperreflexia. , 1986, The Journal of urology.

[2]  J. Fitzpatrick,et al.  Oxybutinin and the prevention of urinary incontinence in spina bifida. , 1985, European urology.

[3]  D. Riva,et al.  Oxybutynin chloride in the treatment of female idiopathic bladder instability. Results from double blind treatment. , 1984, Clinical and experimental obstetrics & gynecology.

[4]  A. Wein,et al.  Direct measurement of the anticholinergic activity of a series of pharmacological compounds on the canine and rabbit urinary bladder. , 1982, The Journal of urology.

[5]  E. Kujansuu,et al.  Scored urological history and urethrocystometry in the differential diagnosis of female urinary incontinence. , 1982, Annales chirurgiae et gynaecologiae.

[6]  C. Brendler,et al.  The urodynamic and subjective results of treatment of detrusor instability with oxybutynin chloride. , 1980, British journal of urology.

[7]  A. Weil,et al.  Motor urge incontinence: diagnosis and treatment. , 1980, Urologia internationalis.

[8]  E. Pedersen.  Studies on the effect and mode of action of flavoxate in human urinary bladder and sphincter. , 1977, Urologia internationalis.

[9]  I. Thompson,et al.  Oxybutynin in bladder spasm, neurogenic bladder, and enuresis. , 1976, Urology.

[10]  A. Diokno,et al.  Oxybutynin: a new drug with analgesic and anticholinergic properties. , 1972, The Journal of urology.

[11]  D. Bradley,et al.  Relief of bladder spasm by flavoxate. A comparative study. , 1970, The Journal of clinical pharmacology and the journal of new drugs.